跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TRULANCE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TRULANCE
Authorized
STANDARD
TRULANCE
bausch health, canada inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1ea797f31f538c48
Company
bausch health, canada inc.
Type
Standard
Approval Details
Approval Id
1ea797f31f538c48
Drug Approval Canada Name
TRULANCE
Product Name
TRULANCE
Status
Marketed
Status Date
2022-01-12
Original Market Date
2022-01-12
Din
02493012
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:92.00
Atc Original
A06AX07 PLECANATIDE
Atc Name
a 06 ax 07
Aig Number
0161890001
Company Name
bausch health, canada inc.
Company Address
2150 Boul. St-Elzear Ouest, Laval, Quebec, Canada, H7L 4A8
Active Ingredients
PLECANATIDE
3 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1ea797f31f538c48
Type
Standard
Back to Health Canada Approvals